Cancer Genetics and Epigenetics, 2025, Vol.13, No.1, 21-31 http://medscipublisher.com/index.php/cge 31 Testa U., Castelli G., and Pelosi E., 2019, Cellular and molecular mechanisms underlying prostate cancer development: therapeutic implications, Medicines, 6(3): 82. https://doi.org/10.3390/medicines6030082 Toor S.M., Nair V.S., Decock J., and Elkord E., 2020, Immune checkpoints in the tumor microenvironment, Seminars in Cancer Biology, 65: 1-2. https://doi.org/10.1016/j.semcancer.2019.06.021 Wang D., Lu G., Shao Y., and Xu D., 2018, MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway, Biomedecine and Pharmacotherapie, 99: 334-339. https://doi.org/10.1016/j.biopha.2018.01.082 Wang J., Ben-David R., Mehrazin R., Yang W., Tewari A., and Kyprianou N., 2023, Novel signatures of prostate cancer progression and therapeutic resistance, Expert Opinion on Therapeutic Targets, 27: 1195-1206. https://doi.org/10.1080/14728222.2023.2293757 Wang L.T., 2024, Genetic mechanisms and clinical significance of HPV16/18 specific variants in cervical cancer, International Journal of Clinical Case Reports, 14(5): 242-252. http://doi.org/10.5376/ijccr.2024.14.0025 Wei G., Zhang H., Zhao H., Wang J., Wu N., Li L., Wu J., and Zhang D., 2021, Emerging immune checkpoints in the tumor microenvironment: Implications for cancer immunotherapy, Cancer Letters, 511: 68-76. https://doi.org/10.1016/j.canlet.2021.04.021 Wikström P., Bergh A., Josefsson A., Thysell E., and Welén K., 2024, Molecular subtypes provide possibilities for precision medicine in a advanced prostate cancer, Lakartidningen, 121: 23179. Xu P., Wasielewski L., Yang J., Cai D., Evans C., Murphy W., and Liu C., 2022, The immunotherapy and immunosuppressive signaling in therapy-resistant prostate cancer, Biomedicines, 10(8): 1778. https://doi.org/10.3390/biomedicines10081778 Zhang T., Karsh L.I., Nissenblatt M.J., and Canfield S., 2020, Androgen receptor splice variant, AR-V7, as a Biomarker of resistance to androgen axis-targeted therapies in advanced prostate cancer, Clinical Genitourinary Cancer, 18(1): 1-10. https://doi.org/10.1016/j.clgc.2019.09.015 Zhang Y., and Wang X., 2020, Targeting the Wnt/β-catenin signaling pathway in cancer, Journal of Hematology and Oncology, 13(1): 165. https://doi.org/10.1186/s13045-020-00990-3
RkJQdWJsaXNoZXIy MjQ4ODYzNA==